Spots Global Cancer Trial Database for Has Inflammation a Significant Implication in Lung Cancer Evolution?

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Has Inflammation a Significant Implication in Lung Cancer Evolution?

Official Title: L'Inflammation A-t-elle Une Implication Significative Dans l'évolution du Cancer Bronchique?

Study ID: NCT02484872

Conditions

Lung Neoplasms

Interventions

Study Description

Brief Summary: Systemic inflammation is a potential prognostic factor in cancer. Inflammation scores as the Glasgow score have been tested in cancer and specifically in lung cancer patients. The aim of the study is to look at the prognostic and predictive value of inflammation during cancer evolution, on the risk of complications leading to ICU admission and the risk of death.

Detailed Description: Patients with newly diagnosed lung cancer will be eligible. All patients will have a blood sampling allowing testing inflammation and cytokine analyses at diagnosis, during work-up and in case of complication.